Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

Introduction Standardized commercial kits enable targeted metabolomics analysis and may thus provide an attractive complement to the more explorative approaches. The kits are typically developed for triple quadrupole mass spectrometers using serum and plasma. Objectives Here we measure the concentra...

Full description

Saved in:
Bibliographic Details
Published in:Metabolomics 2020, Vol.16 (2), p.26-26, Article 26
Main Authors: Carlsson, Henrik, Abujrais, Sandy, Herman, Stephanie, Khoonsari, Payam Emami, Åkerfeldt, Torbjörn, Svenningsson, Anders, Burman, Joachim, Kultima, Kim
Format: Article
Language:English
Subjects:
Biochemistry
Biomedical and Life Sciences
Biomedicine
Cell Biology
Cerebrospinal fluid
Chromatography, Liquid
Cohort Studies
Developmental Biology
Female
Flow Injection Analysis
Glycine
High-resolution mass spectrometry
Humans
Life Sciences
Liquid chromatography
Male
Mass Spectrometry
Mass spectroscopy
Medicin och hälsovetenskap
Metabolites
Metabolomics
Middle Aged
Molecular Medicine
Multiple sclerosis
Multiple Sclerosis - cerebrospinal fluid
Multiple Sclerosis - metabolism
Multiple Sclerosis - pathology
Original
Original Article
Scientific imaging
Secondary progressive multiple sclerosis
Targeted metabolomics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Standardized commercial kits enable targeted metabolomics analysis and may thus provide an attractive complement to the more explorative approaches. The kits are typically developed for triple quadrupole mass spectrometers using serum and plasma. Objectives Here we measure the concentrations of preselected metabolites in cerebrospinal fluid (CSF) using a kit developed for high-resolution mass spectrometry (HRMS). Secondarily, the study aimed to investigate metabolite alterations in patients with secondary progressive multiple sclerosis (SPMS) compared to controls. Methods We performed targeted metabolomics in human CSF on twelve SPMS patients and twelve age and sex-matched healthy controls using the Absolute IDQ-p400 kit (Biocrates Life Sciences AG) developed for HRMS. The extracts were analysed using two methods; liquid chromatography-mass spectrometry (LC-HRMS) and flow injection analysis-MS (FIA-HRMS). Results Out of 408 targeted metabolites, 196 (48%) were detected above limit of detection and 35 were absolutely quantified. Metabolites analyzed using LC-HRMS had a median coefficient of variation (CV) of 3% and 2.5% between reinjections the same day and after prolonged storage, respectively. The corresponding results for the FIA-HRMS were a median CV of 27% and 21%, respectively. We found significantly (p 
ISSN:1573-3882
1573-3890
1573-3890
DOI:10.1007/s11306-020-1648-5